Enteral Feeding of Fibre to Improve Microbiota
Launched by LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST · Feb 23, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how adding fiber to the diet of patients can help improve the balance of good bacteria in the intestines. Many patients who have had surgery to remove part of their bowel may need to have a temporary stoma, where the bowel contents are redirected outside the body. This is necessary to allow the bowel to heal. However, some patients experience complications during or after their surgery, which may be related to changes in the good bacteria that help with digestion. The study aims to find out if giving fiber before surgery can help restore these beneficial bacteria and reduce side effects.
To be eligible for this trial, participants need to be between the ages of 65 and 74 and must be scheduled for surgery to reverse an ileostomy or colostomy (types of surgeries that involve the stoma). They should also be able to understand and communicate in English. If you join the study, you can expect to receive dietary guidance that includes fiber, and researchers will monitor how this affects your recovery. This trial is currently recruiting participants, and it aims to help improve outcomes for patients undergoing these types of surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any individual that has been identified for distal (stoma) feeding that is able to understand verbal and written English to provide informed consent.
- • Participants must be undergoing ileostomy or colostomy reversal surgery.
- Exclusion Criteria:
- • Not undergoing ileostomy or colostomy reversal.
- • Persons who might not adequately understand verbal explanations or written information given in English
About Lancashire Teaching Hospitals Nhs Foundation Trust
Lancashire Teaching Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to delivering high-quality clinical services and advancing medical research. As a prominent sponsor of clinical trials, the Trust is committed to improving patient outcomes through innovative research and evidence-based practices. With a focus on collaboration and patient-centered care, it fosters an environment where multidisciplinary teams work together to explore new treatments and enhance healthcare delivery. The Trust's robust infrastructure and expertise enable it to conduct a wide range of clinical studies, contributing to the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Preston, Lancashire, United Kingdom
Patients applied
Trial Officials
Kina Bennett
Study Chair
Lancashire Teaching Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported